Skip to main content
. 2014 Sep 25;8:101. doi: 10.3389/fnana.2014.00101

Figure 1.

Figure 1

ESP1-immunoreactivity in the tear fluid after removal of the extraorbital lacrimal glands. (A) The surgical area after the incision of the skin in the temporal region of the mouse is photographed. Shown are the extraorbital gland (ELG), the intraorbital gland (ILG), the lacrimal duct and the superficial temporal vein (STV). (B) The lacrimal fluid of seven BALB/c male mice, which underwent the removal of ELGs (ELGx), and of seven sham operated mice (control) was individually collected and analyzed by western blotting with an antibody against ESP1. Tear fluids were also pooled from five BALB/c female mice and used as a negative control. Arrowhead indicates the position of the molecular marker (aprotinin, 6.5 KDa).